Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| RS-2024-00401350 | Other Grant/Funding Number | Korea Health Industry Development Institute |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intrevention group (digital therapeutics) | Experimental |
| |
| control group (usual care) | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| digital therapeutics | Other | After rotator cuff repair surgery, the patient performed prescribed rehabilitation exercises delivered through a personal mobile device |
|
| Measure | Description | Time Frame |
|---|---|---|
| American Shoulder and Elbow Surgeons score (ASES) | domain : pain, function
This results in a final combined score ranging from 0 to 100, with higher scores indicating better shoulder function. | baseline, 9-week, 15-week, 22-week, 46-week |
| Measure | Description | Time Frame |
|---|---|---|
| Constant score | The scoring system ranges from 0 to 100 points, with higher scores indicating better shoulder function. It includes the following components: pain (15 points), activities of daily living (20 points), active range of motion (ROM) (40 points), and muscle strength (25 points). Muscle strength is measured by assessing force in 90-degree shoulder abduction and then converted into a score. |
| Measure | Description | Time Frame |
|---|---|---|
| Self-efficacy for exercise (SEE) | The scale consists of 9 items describing situations that hinder exercise. It uses a 0% (not confident at all) to 100% (extremely confident) scale, with intervals of 10%, assessing the patient's confidence in being able to exercise for 20 minutes, three times a week in each situation. Scores are interpreted as follows: 0-20% = not confident at all, 20-40% = slightly confident, 40-60% = moderately confident, 60-80% = very confident, and 80-100% = extremely confident. |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Samsung medical center | Recruiting | Seoul | Republic of Korea | 06351 | South Korea |
Since this provides the subject's personal information to a third party, separate consent is required.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000070656 | Rotator Cuff Tear Arthropathy |
| ID | Term |
|---|---|
| D002805 | Chondrocalcinosis |
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
Not provided
Not provided
Prospective, randomized controlled, 1:1 allocation, total participants 70
Not provided
Not provided
Not provided
| usual care | Other | Before discharge and at the first postoperative visit (2 weeks after surgery), patients receive education based on a brochure covering rehabilitation exercises, surgical site care, and criteria for hospital visits in emergency situations. The brochure includes information on the duration of brace use, surgical site hygiene and care, precautions for arm use, and detailed rehabilitation exercise instructions. At follow-up visits around 8 and 20 weeks post-surgery, patients receive guidance on improving joint range of motion and muscle strengthening exercises. Physical therapy modalities such as cold and heat application and electrical stimulation are provided. Additional treatments, including corticosteroid injections combined with hyaluronic acid, may be administered based on the healthcare provider's clinical judgment. |
|
| baseline, 9-week, 22-week, 46-week |
| Korean shoulder Score (KSS) | The scale ranges from 0 to 100 points, with higher scores indicating better function. It is composed of the following components: pain (30 points), function (40 points), activities of daily living (10 points), muscle strength (20 points), and satisfaction (10 points). | baseline, 9-week, 22-week, 46-week |
| Simple shoulder Test (SST) | The score ranges from 0 to 12 points, with higher scores indicating better function. It is an outcome measure consisting of 12 yes/no questions related to function. Each "yes" response is scored as 1 point, and the total number of "yes" answers is summed to calculate the final score. This tool provides a simple patient-reported outcome to briefly assess the ability to perform daily activities. | baseline, 9-week, 22-week, 46-week |
| Shoulder pain (PVAS) | Evaluated during rest and activity. Pain is assessed using an 11-point scale (0-10 points) evaluating overall shoulder pain over the past 7 days. A lower score indicates an improvement in pain. | baseline, 9-week, 15-week, 22-week, 46-week |
| Shoulder joint range of motion (active) | A. Forward flexion (0-180 degrees), abduction (0-180 degrees), and external rotation at the side with the upper arm beside the torso (0-90 degrees) are measured using a goniometer to record the maximum angles. Higher values indicate better shoulder mobility. B. Internal rotation at the back: When the arm is placed behind the back, the level of the spine reached by the tip of the thumb is measured and scored accordingly (thoracic vertebrae T1-T12 = 1-12 points; lumbar vertebrae L1-L5 = 13-17 points; buttock = 18 points). Higher scores indicate better shoulder mobility. | 9-week, 15-week, 22-week, 46-week |
| Shoulder joint range of motion (passive) | A. Forward flexion (0-180 degrees), abduction (0-180 degrees), and external rotation at the side with the upper arm beside the torso (0-90 degrees) are measured using a goniometer to record the maximum angles. Higher values indicate better shoulder mobility. B. Internal rotation at the back: When the arm is placed behind the back, the level of the spine reached by the tip of the thumb is measured and scored accordingly (thoracic vertebrae T1-T12 = 1-12 points; lumbar vertebrae L1-L5 = 13-17 points; buttock = 18 points). Higher scores indicate better shoulder mobility. | baseline, 9-week, 15-week, 22-week, 46-week |
| Shoulder muscle strength (Isokinetic) | Isokinetic muscle strength is measured for each movement following a standardized protocol using an isokinetic dynamometer (HUMAN NORM; exercise testing and evaluation device; classification number A30130.01, Class 2 medical device). During the test, the subject sits on a chair with the trunk fixed to the dynamometer. The subject holds the handle on the opposite side of the dynamometer. Higher values indicate better muscle strength. Internal and external rotation: The arm is abducted to 45 degrees in the scapular plane with the elbow flexed to 90 degrees. External rotation range of motion is set at 65 degrees and internal rotation at 25 degrees. Measurements are taken at an angular velocity of 60 degrees per second for 4 repetitions (strength) and 180 degrees per second for 10 repetitions (muscular endurance), recording peak torque in pounds. | baseline, 22-week, 46-week |
| Shoulder muscle strength (Isometric) | Using a hand-held dynamometer (FGN-20B, SHIMPO, JAPAN), the maximum force (in pounds) is collected and measured in the internal rotation (at side), external rotation (at side), and scaption positions. | baseline, 9-week, 22-week, 46-week |
| Global change rating (GRoC) | The overall change assessment scale ranges from -5 (much worse) to 5 (much improved) points, evaluating the patient's perception of overall functional recovery and satisfaction with their general condition. Compared to pre-surgery, a change of 2 points or more at the end of intervention (T3), and similarly from T3 to the end of follow-up (T4), is interpreted as the minimum clinically important difference. | 22-week, 46-week |
| baseline, 9-week, 15-week, 22-week, 46-week |
| World Health Organization Disability Assessment Schedule (WHODAS 2.0) | The assessment evaluates difficulties experienced over the past 30 days and consists of 36 items covering six core domains: cognition, mobility, self-care, interpersonal relationships, activities of daily living, and social participation. Each item is rated on a 5-point Likert scale from "no difficulty at all (0 points)" to "extreme difficulty or impossible (4 points)." The total score is calculated by summing all domain scores, ranging from 0 to 100 points. Higher scores indicate greater functional difficulty and a higher level of disability, while lower scores represent better function and lower disability. | baseline, 9-week, 15-week, 22-week, 46-week |
| (K-eHEALS) | Health literacy is assessed by measuring the ability to search for, understand, evaluate, and utilize health information. Scores range from a minimum of 8 to a maximum of 40 points, with higher scores indicating better literacy. A score of 24 or below (criteria may vary by study) suggests a high likelihood of difficulty in searching for and using health information on the internet. | baseline |
| System Usability Scale (SUS) | It consists of 10 items designed to evaluate the usability of the system, with a score range from 0 to 100. Higher scores indicate that the system is easier and more convenient to use. | 22-week |
| Satisfaction with the clinical trial medical device (mobile application) | A survey is conducted to assess overall mobile app satisfaction, perceived usefulness, perceived ease of use (PEOU), attitude toward using technology, and behavioral intention to use. A Likert scale (1-5 points) is used, with higher scores interpreted as indicating a greater likelihood of technology acceptance. | 22-week |
| Resource Utilization | This investigates the occurrence and frequency of any additional external treatments the patient received aside from the intervention provided by the institution (including visits to other hospitals, imaging tests, physical therapy, injections/procedures, medications, etc.) and collects perceived benefit scores (0-10 points). This monitoring helps identify protocol violations and evaluates additional medical and economic burdens between the two groups, potentially revealing cost advantages. | 22-week, 46-week |
| D000070657 |
| Crystal Arthropathies |